Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.56T | 2.46T | 2.49T | 1.88T | 2.21T |
Gross Profit | 505.89B | 443.52B | 420.83B | 377.50B | 438.36B |
EBITDA | 265.29B | 207.84B | 219.00B | 252.43B | 206.08B |
Net Income | 77.91B | 21.90B | 72.82B | 45.79B | 45.79B |
Balance Sheet | |||||
Total Assets | 3.29T | 3.47T | 3.19T | 2.85T | 2.65T |
Cash, Cash Equivalents and Short-Term Investments | 254.52B | 248.86B | 254.69B | 242.49B | 173.70B |
Total Debt | 842.66B | 949.68B | 950.09B | 973.93B | 913.56B |
Total Liabilities | 1.47T | 1.62T | 1.56T | 1.53T | 1.47T |
Stockholders Equity | 1.71T | 1.74T | 1.54T | 1.24T | 1.10T |
Cash Flow | |||||
Free Cash Flow | 75.78B | 51.55B | 43.00B | 89.11B | 85.62B |
Operating Cash Flow | 255.03B | 185.68B | 145.21B | 211.59B | 225.77B |
Investing Cash Flow | -63.20B | -121.00B | -102.72B | -97.87B | -142.36B |
Financing Cash Flow | -188.52B | -70.37B | -57.38B | -69.40B | -67.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $2.17B | 28.90 | 8.32% | 1.48% | 1.17% | -30.24% | |
69 Neutral | $11.11B | 21.74 | 4.47% | 0.09% | -1.29% | 224.05% | |
57 Neutral | HK$26.04B | 4.10 | -2.03% | 5.50% | -0.23% | -68.02% | |
55 Neutral | $86.85M | ― | -15.73% | ― | 2.51% | 32.95% | |
52 Neutral | $142.34M | ― | -17.61% | 0.80% | 34.28% | -495.11% |